Adenosarcomas are rare tumors that typically occur in the uterus. It accounts for approximately 1 – 3% of all female genital tract malignancies. Rarer still are cervical adenosarcomas, accounting for only 2% of all genital tract adenosarcoma with only few reported cases in literature, and the second reported case in the Philippines. Unlike other cervical malignancies that are HPV related, adenosarcoma of the cervix may arise from a pre-existing endometriosis or a history of recurrent cervical polyp. This is a case of a 37 year old G3P3 (3003), who had been having dysmenorrhea and later had abnormal vaginal bleeding. On her initial consult, she was diagnosed with cervical polyp and later, biopsy showed leiomyosarcoma. She underwent radical hysterectomy with bilateral salpingooophorectomy and bilateral lymphadenectomy. Final histopathology showed a poorly differentiated adenosarcoma of the cervix with stromal invasion. She was given adjuvant treatment in the form of chemotherapy and brachytherapy post surgery. At present the patient had no evidence of disease. Due to its rarity, there is no existing recommendation or consensus regarding the surgery of choice and on the adjuvant treatment for cervical adenosarcoma. Here we review the possible etiology, and the different management and treatment options to optimally manage such a rare case.